Trevi Therapeutics Inc. (TRVI)
NASDAQ: TRVI
· Real-Time Price · USD
7.49
0.00 (0.00%)
At close: Aug 15, 2025, 1:14 PM
0.00% (1D)
| Bid | 7.48 |
| Market Cap | 911.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.35M |
| EPS (ttm) | -0.42 |
| PE Ratio (ttm) | -17.82 |
| Forward PE | -13.74 |
| Analyst | Buy |
| Ask | 7.49 |
| Volume | 365,894 |
| Avg. Volume (20D) | 1,920,204 |
| Open | 7.56 |
| Previous Close | 7.49 |
| Day's Range | 7.37 - 7.57 |
| 52-Week Range | 2.36 - 8.11 |
| Beta | 0.59 |
About TRVI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRVI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRVI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-5.85%
Trevi Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
2 months ago
-2.92%
TRVI stock has given up its prior gain. Trevi Therapeutics shares were trading higher after the company announced positive topline results from its Phase 2b CORAL trial of Haduvio.
2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Acquires Shares of 14,059 Trevi Therapeutics, Inc. (NASDAQ:TRVI)Squarepoint Ops LLC acquired a new stake in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities...
